✓ Medically reviewed by · Last reviewed: May 2026
Pharmacy Researcher · 8 years experience
Pharmacy researcher with 8 years reviewing clinical drug information, generic formulation equivalence, and international pharmaceutical standards. Focuses on patient-facing accuracy in medication education.
Quick Answer
- Glycimep is one of India’s many brand names for glimepiride, a second-generation sulfonylurea used to lower blood sugar in type 2 diabetes.
- The plain “Glycimep” tablet contains glimepiride alone (commonly 1 mg or 2 mg). Combination versions add other molecules — see the composition table below.
- Glycimep works by prompting the pancreas to release more insulin, so it only helps people who still produce some of their own insulin.
- MedsBase does not stock the Glycimep label, but the identical glimepiride molecule is available as Amaryl (the originator brand), Glypride and Glimda — all from WHO-GMP-certified manufacturers, no prescription needed.
If you have searched for “Glycimep” and landed on pages about an unrelated drug, you are not alone — the brand is widely advertised but poorly documented in English. This guide explains exactly what Glycimep is, what each version contains, how glimepiride works, how it is dosed, the side effects that matter most, and where you can buy the same active ingredient online.
What Is Glycimep?
Glycimep is a trade name for glimepiride, an oral antidiabetic medicine in the sulfonylurea class. It is marketed by an Indian pharmaceutical company and sold across several formulations, which is why searches for “Glycimep composition” return so many different answers. The constant across every version is the sulfonylurea component — glimepiride — which is the part doing most of the blood-sugar-lowering work.
Glimepiride itself is a globally established molecule. It is the active ingredient in Sanofi’s originator brand Amaryl and has been used worldwide since the 1990s. “Glycimep” is simply one of dozens of generic brand names — alongside Glypride, Glimda, Glimestar, Zoryl and many others — that contain the same compound. The brand on the box changes; the medicine inside does not.
Why “Glycimep” returns confusing results
Several Glycimep variants exist (plain glimepiride, glimepiride + metformin, glimepiride + metformin + voglibose, and a separate metformin-only SR line). Search engines often blend these together, so a query for the plain tablet can surface a combination product’s leaflet. Always check the full molecule name and strength printed on the strip rather than trusting the brand alone.
Glycimep Composition & Variants
The Glycimep family follows the same naming logic used by most Indian glimepiride ranges. Here is how the common versions break down:
| Variant | Active ingredients | What it is for |
|---|---|---|
| Glycimep (plain) | Glimepiride 1 mg / 2 mg / 4 mg | Single-agent sulfonylurea — usually added when diet plus metformin is not enough |
| Glycimep GP / GP1 / GP2 | Glimepiride 1–2 mg + Metformin 500 mg | Fixed-dose combination — two mechanisms in one tablet |
| Glycimep MV / MV1 | Glimepiride + Metformin + Voglibose | Triple combination for harder-to-control post-meal sugars |
| Glycimep SR | Metformin 500 mg (sustained-release) — no glimepiride | Metformin-only line; easy to confuse with the glimepiride tablets |
If you have been prescribed “Glycimep” without a suffix, it is almost always the plain glimepiride tablet. The GP, MV and SR codes signal added molecules, and they are not interchangeable — switching between them without medical guidance can change both your blood-sugar control and your risk of low sugar.
How Glimepiride Works
Glimepiride belongs to the sulfonylurea family, which lowers blood glucose through a single, well-understood mechanism:
- It stimulates insulin release. Glimepiride binds to receptors on the beta cells of the pancreas, closing potassium channels and triggering the cells to secrete more insulin.
- It improves insulin sensitivity modestly. Some evidence suggests glimepiride also helps peripheral tissues respond a little better to insulin, though this is secondary to its main action.
- It depends on a working pancreas. Because the drug squeezes more insulin out of the beta cells, it only helps people with type 2 diabetes who still make some insulin. It is not used for type 1 diabetes.
This mechanism is what separates glimepiride from metformin, which lowers sugar mainly by reducing glucose production in the liver and does not push insulin levels up. The two are frequently combined precisely because they work in different ways — covered in detail in our glimepiride vs metformin comparison.
What Glycimep (Glimepiride) Treats
Glimepiride is used to manage type 2 diabetes mellitus in adults, typically when blood sugar is not adequately controlled by diet, exercise and metformin alone. In practice it is used:
- As an add-on to metformin when HbA1c remains above target
- As part of a fixed-dose combination (the Glycimep GP and MV variants) to simplify a regimen
- Occasionally as monotherapy in people who cannot tolerate metformin
It is not a treatment for type 1 diabetes, diabetic ketoacidosis, or for managing weight. Glimepiride does not cause weight loss the way GLP-1 medicines do; if weight is a priority, the newer injectable classes covered in our Ozempic vs metformin guide may be more relevant to discuss with a clinician.
Glycimep Dosage & How to Take It
Glimepiride is taken once daily. The standard approach is “start low, go slow” to minimise the risk of low blood sugar:
| Stage | Typical dose | Notes |
|---|---|---|
| Starting dose | 1Â mg once daily | Older adults and those with kidney issues usually start here |
| Titration | Increase by 1–2 mg every 1–2 weeks | Guided by fasting and HbA1c readings |
| Usual maintenance | 1–4 mg once daily | Most people are controlled within this range |
| Maximum | 8Â mg once daily | Higher doses rarely add benefit and raise hypoglycaemia risk |
- Take it with breakfast — or the first main meal of the day. Taking it on an empty stomach increases the chance of low blood sugar.
- Never skip the meal after your dose. If you take Glycimep and then miss breakfast, your sugar can drop dangerously low.
- Do not double up if you miss a dose — take the next one as normal.
Hypoglycaemia is the main risk — know the signs
Because glimepiride forces insulin release whether or not you have eaten, low blood sugar (hypoglycaemia) is its most important side effect. Early warning signs include shakiness, sweating, hunger, a racing heart, confusion and dizziness. Treat it immediately with fast-acting sugar (glucose tablets, juice or sweets), then a snack. Severe or repeated lows need urgent medical attention.
Glycimep (Glimepiride) Side Effects
Most people tolerate glimepiride well, but it is important to know the full picture:
- Common: low blood sugar, dizziness, headache, nausea, and mild weight gain (a known sulfonylurea effect).
- Less common: skin rash or itching, sensitivity to sunlight, and gastrointestinal upset.
- Rare but serious: severe hypoglycaemia, significant allergic reactions, and — very rarely — changes in blood counts or liver enzymes.
The hypoglycaemia risk is higher in older adults, people with kidney or liver impairment, those who drink alcohol, and anyone who eats irregularly. If you experience repeated low-sugar episodes, your dose likely needs adjusting — do not simply stop the medicine without advice, as uncontrolled high sugar carries its own risks.
Warnings & Drug Interactions
- Alcohol can both intensify and mask hypoglycaemia — limit it and never drink on an empty stomach while taking glimepiride.
- Other glucose-lowering drugs (insulin, other sulfonylureas, some antibiotics and beta-blockers) can amplify the blood-sugar-lowering effect.
- Kidney and liver disease change how glimepiride is cleared and raise the risk of prolonged lows — lower starting doses are used.
- Pregnancy and breastfeeding — glimepiride is generally avoided; insulin is preferred. Discuss alternatives with a clinician.
- Driving — be cautious until you know how the medicine affects you, since hypoglycaemia impairs concentration.
Who is glimepiride a good fit for?
Glimepiride suits adults with type 2 diabetes who still produce insulin and need an affordable, once-daily add-on to metformin. It is less suitable for people prone to hypoglycaemia, those who skip meals, the frail elderly, or anyone whose main goal is weight loss. A clinician can confirm whether a sulfonylurea or a different class fits your profile.
Glycimep vs Other Glimepiride Brands
Since the active ingredient is identical, the choice between Glycimep and any other glimepiride brand comes down to availability, manufacturer quality and price. At MedsBase you can order the same molecule under brands we stock and verify:
- Amaryl — Sanofi’s originator glimepiride brand; the reference product the generics are matched against.
- Glypride and Glimda — WHO-GMP-certified glimepiride generics offering the same therapeutic effect at a lower price.
- Glycomet-GP and Amaryl M — the glimepiride + metformin fixed-dose combinations, equivalent to the Glycimep GP line.
Whichever brand you choose, the key is that the tablet comes from a WHO-GMP-certified manufacturer with verified glimepiride content. Brand loyalty to a specific name like “Glycimep” rarely changes outcomes; consistency of source and strength does. Browse the full range on our diabetes medication page.
Where to Buy Glimepiride Online
MedsBase ships glimepiride and its combinations worldwide, no prescription needed, sourced from WHO-GMP-certified manufacturers. If you have been buying “Glycimep” locally and want a verified, consistent supply, the equivalent products above are the closest match — same molecule, same strengths (1 mg, 2 mg, 4 mg), with transparent composition on every listing. Worldwide Shipping is available on all diabetes lines.
Frequently Asked Questions
What is the composition of Glycimep?
The plain Glycimep tablet contains glimepiride (commonly 1Â mg or 2Â mg). The Glycimep GP versions add metformin 500Â mg, the MV versions add metformin plus voglibose, and the Glycimep SR line is metformin-only sustained-release with no glimepiride. Always confirm the molecule and strength printed on your strip.
Is Glycimep the same as glimepiride?
Yes — Glycimep is a brand name for glimepiride. The medicine inside is the same sulfonylurea sold under other brands such as Amaryl, Glypride and Glimda.
Who manufactures Glycimep?
Glycimep is one of many glimepiride brands marketed in India by a third-party company. Because the molecule is generic, the manufacturer behind a given brand can vary. MedsBase does not stock the Glycimep label specifically, but supplies the identical glimepiride molecule under verified, WHO-GMP-certified brands.
What is the difference between Glycimep and Glycimep GP?
Plain Glycimep is glimepiride alone. Glycimep GP is a fixed-dose combination of glimepiride plus metformin, giving you two complementary mechanisms in one tablet. They are not interchangeable — switching changes both your control and your hypoglycaemia risk.
When should I take glimepiride?
Take it once daily with breakfast or your first main meal. Never take it and then skip the meal, as this is the most common cause of low blood sugar on this medicine.
Does glimepiride cause weight gain?
Mild weight gain is a recognised effect of sulfonylureas, including glimepiride. If weight is a major concern, ask your clinician about classes that are weight-neutral or promote weight loss.
Can I buy glimepiride online without a prescription?
Yes — MedsBase supplies glimepiride and its combinations worldwide with no prescription needed, all from WHO-GMP-certified manufacturers. Self-managing a sulfonylurea still requires care, so blood-sugar monitoring and clinical follow-up are strongly recommended.
Medical disclaimer: This article is for general information only and is not a substitute for professional medical advice. Glimepiride can cause serious low blood sugar. Always consult a qualified healthcare professional before starting, stopping or changing any diabetes medication, and monitor your blood glucose as advised.
Written by
Sophie ChenPharmaceutical Content Researcher · 8 years experience
Sophie Chen is a pharmaceutical content researcher with 8 years covering generic medication access and clinical pharmacology. She specialises in international regulatory frameworks, bioequivalence standards, and patient-facing education on therapeutic drug classes. She is not a clinician.